Papers/PMID:38808890
Tolerability of glutamine supplementation in older adults: a double-blind placebo-controlled randomized clinical trial.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas2024The record
1 finding drawn from this paper, on 1 compound across 1 endpoint, 1 of them null.
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
L-glutamine — no detected effect on glycated haemoglobin (HbA1c)
LikelyGrade B, Likely. Human evidence, limited replication or design limits.FindingNull result“Fasting glycemia and glycated hemoglobin A1c values before and after 60 days of supplementation with EGln or maltodextrin indicated prediabetes, but no significant differences were observed between the EGln and placebo groups.”
Quoted verbatim from Tolerability of glutamine supplementation in older adults: a double-blind placebo-controlled randomized clinical trial.. - Study
- RCT
- Participants
- 30
- Duration
- 2 months
- Dose
- 12.4 g oral effervescent glutamine daily
- Population
- community-dwelling older adults aged over 60 from three daycare centres in Brazil; safety/tolerability endpoint, not the trial's primary outcome
Tolerability of glutamine supplementation in older adults: a double-blind placebo-controlled randomized clinical trial.2024PMID:38808890